#ALNY (Alnylam Pharmaceuticals Inc.). 汇率和在线图表。

#ACB 返回工具列表 #AMGN

货币转换器

292.06 USD
10 Jun 2026 21:59

$-0.03
(-0.01%)

前收

$297.43

开盘

$291.74

当日高点

$299.18

当日低点

$291.83

52周高点

$300.17

52周低点

$284.43

下载档案

以全屏视图打开图表

下载档案

以全屏视图打开图表

Alnylam Pharmaceuticals Inc. About company

Alnylam Pharmaceuticals Inc. is an American biopharmaceutical company, founded in 2002. The firm is mainly involved in the research and development of drugs for treating genetic disorders.

In 2016, Alnylam Pharmaceuticals Inc. was added to the Forbes list of the world’s 100 most innovative growth companies.

This year, the market capitalization of Alnylam Pharmaceuticals Inc. totals $17.65 billion. In 2021, it raised revenue of $844.29 million. In the first six months of 2022, the company earned as much as $224.82 million.

Alnylam Pharmaceuticals Inc.’s shares and factors shaping their value

The company has been listed on the NASDAQ exchange since 2004 under the ALNY ticker. Its share value currently totals $200-205. Over the past 12 months, ALNY has fluctuated in the range of $117 to $236.

When trading the firm’s stock, you should pay attention to the following factors:

The company has a heavy dependence on the state of the healthcare sector as a whole. Thus, new COVID outbreaks have a negative influence on its revenue growth;
The company occasionally introduces new drugs to the market, conducting clinical and laboratory trials and publishing the results beforehand;
Constantly growing revenues are the firm’s advantage;
Enough own funds to finance projects without the need to additionally issue securities.

InstaSpot – 数以百万计的客户信任我们！您的选择胜于雄辩！

像奥列格·塔克塔罗维一样保持健康和成功！InstaSpot品牌大使之间明亮的开始！

货币转换器

Alnylam Pharmaceuticals Inc. About company

Alnylam Pharmaceuticals Inc.’s shares and factors shaping their value